|
Volumn 35, Issue 4, 2007, Pages 663-667
|
Anti-osteoporosis activity of naringin in the retinoic acid-induced osteoporosis model
|
Author keywords
Naringin; Retinoic Acid; Treatment of Osteoporosis
|
Indexed keywords
ALKALINE PHOSPHATASE;
AURANTIIN;
CALCIUM;
ETIDRONIC ACID;
PHOSPHORIC ACID;
RETINOIC ACID;
ALKALINE PHOSPHATASE BLOOD LEVEL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
ASH;
BIOLOGICAL ACTIVITY;
BLOOD ANALYSIS;
BONE DENSITY;
BONE MASS;
CONTROLLED STUDY;
DRUG DOSE COMPARISON;
DRUG EFFICACY;
DRUG ISOLATION;
DRUG MECHANISM;
DRUG MEGADOSE;
FEMALE;
FEMUR;
IN VITRO STUDY;
IN VIVO STUDY;
LOW DRUG DOSE;
MORPHOMETRICS;
NONHUMAN;
OSTEOPOROSIS;
RAT;
ALKALINE PHOSPHATASE;
ANIMALS;
BONE DENSITY;
CALCIUM;
DISEASE MODELS, ANIMAL;
FEMALE;
FEMUR;
FLAVANONES;
MINERALS;
OSTEOGENESIS;
OSTEOPOROSIS;
PHOSPHORUS;
PHYTOTHERAPY;
RANDOM ALLOCATION;
RATS;
RATS, SPRAGUE-DAWLEY;
TRETINOIN;
|
EID: 34548174431
PISSN: 0192415X
EISSN: None
Source Type: Journal
DOI: 10.1142/S0192415X07005156 Document Type: Article |
Times cited : (95)
|
References (4)
|